Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Yuxiao Wang, Jingxin Li, Pinyuan Dai, Pei Liu & Fengcai Zhu. (2021) Effectiveness of the oral human attenuated pentavalent rotavirus vaccine (RotaTeq™) postlicensure: a meta-analysis—2006–2020. Expert Review of Vaccines 20:4, pages 437-448.
Read now
Read now
Yuxiao Wang, Jingxin Li, Pei Liu & Fengcai Zhu. (2021) The performance of licensed rotavirus vaccines and the development of a new generation of rotavirus vaccines: a review. Human Vaccines & Immunotherapeutics 17:3, pages 880-896.
Read now
Read now
A. Duncan Steele, Shabir A. Madhi, Nigel A. Cunliffe, Timo Vesikari, Kong Boo Phua, Fong Seng Lim, E. Anthony S. Nelson, Yu-Lung Lau, Li-Min Huang, Naveen Karkada, Serge Debrus, Htay Htay Han & Bernd Benninghoff. (2016) Incidence of rotavirus gastroenteritis by age in African, Asian and European children: Relevance for timing of rotavirus vaccination. Human Vaccines & Immunotherapeutics 12:9, pages 2406-2412.
Read now
Read now
Victoria Jiang, Baoming Jiang, Jacqueline Tate, Umesh D. Parashar & Manish M. Patel. (2010) Performance of rotavirus vaccines in developed and developing countries. Human Vaccines 6:7, pages 532-542.
Read now
Read now
Jacqueline E Tate, Manish M Patel, A Duncan Steele, Jon R Gentsch, Daniel C Payne, Margaret M Cortese, Osamu Nakagomi, Nigel A Cunliffe, Baoming Jiang, Kathleen M Neuzil, Lucia H de Oliveira, Roger I Glass & Umesh D Parashar. (2010) Global impact of rotavirus vaccines. Expert Review of Vaccines 9:4, pages 395-407.
Read now
Read now
Timo Vesikari. (2008) Rotavirus vaccines. Scandinavian Journal of Infectious Diseases 40:9, pages 691-695.
Read now
Read now
Tarja Ruuska & Timo Vesikari. (1990) Rotavirus Disease in Finnish Children: Use of Numerical Scores for Clinical Severity of Diarrhoeal Episodes. Scandinavian Journal of Infectious Diseases 22:3, pages 259-267.
Read now
Read now
Articles from other publishers (39)
Eric J. Chow, Mark W. Tenforde, Melissa A. Rolfes, Benjamin Lee, Shreya Chodisetty, Julio A. Ramirez, Alicia M. Fry & Manish M. Patel. (2021) Differentiating severe and non-severe lower respiratory tract illness in patients hospitalized with influenza: Development of the Influenza Disease Evaluation and Assessment of Severity (IDEAS) scale. PLOS ONE 16:10, pages e0258482.
Crossref
Crossref
Olufemi Samuel Folorunso & Olihile M. Sebolai. (2020) Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines. Vaccines 8:3, pages 341.
Crossref
Crossref
Graeme L Barnes. (2018) Rotavirus vaccine: a single birth dose?. The Lancet Infectious Diseases 18:7, pages 714-715.
Crossref
Crossref
Yoshiki Kawamura, Kensei Gotoh, Nao Takeuchi, Hiroki Miura, Naoko Nishimura, Takao Ozaki & Tetsushi Yoshikawa. (2016) Role of matrix metalloproteinases in the pathogenesis of childhood gastroenteritis. Journal of Medical Virology 88:8, pages 1341-1346.
Crossref
Crossref
Sana Hosny Barakat, Reem Abdel Hameed Harfoush & Sherif Mostafa Dabbour. (2016) Rotavirus infection markers in children with rotaviral gastroenteritis and their relation to disease severity. Pediatric Infectious Disease 8:1, pages 8-14.
Crossref
Crossref
Timo Vesikari. (2015) Neonatal rotavirus vaccination making headway. The Lancet Infectious Diseases 15:12, pages 1362-1363.
Crossref
Crossref
Julie E Bines, Margaret Danchin, Pamela Jackson, Amanda Handley, Emma Watts, Katherine J Lee, Amanda West, Daniel Cowley, Mee-Yew Chen, Graeme L Barnes, Frances Justice, Jim P Buttery, John B Carlin, Ruth F Bishop, Barry Taylor & Carl D Kirkwood. (2015) Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial. The Lancet Infectious Diseases 15:12, pages 1389-1397.
Crossref
Crossref
Michelle J Groome, Nicola Page, Margaret M Cortese, Jocelyn Moyes, Heather J Zar, Constant N Kapongo, Christine Mulligan, Ralph Diedericks, Cheryl Cohen, Jessica A Fleming, Mapaseka Seheri, Jeffrey Mphahlele, Sibongile Walaza, Kathleen Kahn, Meera Chhagan, A Duncan Steele, Umesh D Parashar, Elizabeth R Zell & Shabir A Madhi. (2014) Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study. The Lancet Infectious Diseases 14:11, pages 1096-1104.
Crossref
Crossref
George E. Armah, Albert Z. Kapikian, Timo Vesikari, Nigel Cunliffe, Robert M. Jacobson, D. Bruce Burlington & Leonard P. RuizJrJr. (2013) Efficacy, Immunogenicity, and Safety of Two Doses of a Tetravalent Rotavirus Vaccine RRV-TV in Ghana With the First Dose Administered During the Neonatal Period. The Journal of Infectious Diseases 208:3, pages 423-431.
Crossref
Crossref
Timo Vesikari. (2013) Intussusception After Human Rotavirus Vaccine. Pediatric Infectious Disease Journal 32:5, pages 579-580.
Crossref
Crossref
Anupam Mukherjee, Shiladitya Chatopadhyay & Mamta Chawla-Sarkar. (2012) Rotavirus Infection in India: A Major Cause of Childhood Gastroenteritis. Proceedings of the National Academy of Sciences, India Section B: Biological Sciences 82:1, pages 135-151.
Crossref
Crossref
Anupam Mukherjee & Mamta Chawla-Sarkar. (2011) Rotavirus Infection: A Perspective on Epidemiology, Genomic Diversity and Vaccine Strategies. Indian Journal of Virology 22:1, pages 11-23.
Crossref
Crossref
Harry B. Greenberg & Mary K. Estes. (2009) Rotaviruses: From Pathogenesis to Vaccination. Gastroenterology 136:6, pages 1939-1951.
Crossref
Crossref
Shobha D. Chitambar, Vaishali S. Tatte, Ram Dhongde & Vijay Kalrao. (2008) High frequency of rotavirus viremia in children with acute gastroenteritis: Discordance of strains detected in stool and sera. Journal of Medical Virology 80:12, pages 2169-2176.
Crossref
Crossref
Timo Vesikari, Pierre Van Damme, Carlo Giaquinto, Jim Gray, Jacek Mrukowicz, Ron Dagan, Alfredo Guarino, Hania Szajewska & Vytautas Usonis. (2008) European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition Evidence-Based Recommendations for Rotavirus Vaccination in Europe. Journal of Pediatric Gastroenterology & Nutrition 46:Suppl 2, pages S38-S48.
Crossref
Crossref
Jim Gray, Timo Vesikari, Pierre Van Damme, Carlo Giaquinto, Jacek Mrukowicz, Alfredo Guarino, Ron Dagan, Hania Szajewska & Vytautas Usonis. (2008) Rotavirus. Journal of Pediatric Gastroenterology & Nutrition 46:Suppl 2, pages S24-S31.
Crossref
Crossref
Timo Vesikari, Pierre Van Damme, Carlo Giaquinto, Jim Gray, Jacek Mrukowicz, Ron Dagan, Alfredo Guarino, Hania Szajewska & Vytautas Usonis. (2008) European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition Evidence-Based Recommendations for Rotavirus Vaccination in Europe: Executive Summary. Journal of Pediatric Gastroenterology & Nutrition 46:5, pages 615-618.
Crossref
Crossref
H. Melliez, D. Levybruhl, P.Y. Boelle, B. Dervaux, S. Baron & Y. Yazdanpanah. (2008) Cost and cost-effectiveness of childhood vaccination against rotavirus in France. Vaccine 26:5, pages 706-715.
Crossref
Crossref
Timo Vesikari, Aino Karvonen, Bruce D. Forrest, Yasutaka Hoshino, Robert M. Chanock & Albert Z. Kapikian. (2006) Neonatal Administration of Rhesus Rotavirus Tetravalent Vaccine. Pediatric Infectious Disease Journal 25:2, pages 118-122.
Crossref
Crossref
Timo Vesikari, Carlo Giaquinto & Hans-Iko Huppertz. (2006) Clinical Trials of Rotavirus Vaccines in Europe. Pediatric Infectious Disease Journal 25:1, pages S42-S47.
Crossref
Crossref
H. Melliez, P.-Y. Boelle, S. Baron, Y. Mouton & Y. Yazdanpanah. (2005) Morbidité et coût des infections à rotavirus en France. Médecine et Maladies Infectieuses 35:10, pages 492-499.
Crossref
Crossref
Karla Soares-Weiser, Elad Goldberg, Ghandi Tamimi, Leonard Leibovici & Femi Pitan. (2004) Rotavirus vaccine for preventing diarrhoea. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Baoming Jiang, Jon R. Gentsch & Roger I. Glass. (2002) The Role of Serum Antibodies in the Protection against Rotavirus Disease: An Overview. Clinical Infectious Diseases 34:10, pages 1351-1361.
Crossref
Crossref
YOSHIYUKI SAKAI, SHUJI NAKATA, SHINJIRO HONMA, MASATOSHI TATSUMI, KAZUKO NUMATA-KINOSHITA & SHUNZO CHIBA. (2001) Clinical severity of Norwalk virus and Sapporo virus gastroenteritis in children in Hokkaido, Japan. The Pediatric Infectious Disease Journal 20:9, pages 849-853.
Crossref
Crossref
Joseph S Bresee, Roger I Glass, Bernard Ivanoff & Jon R Gentsch. (1999) Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries1Prepared as a review for the Consensus Workshop on Rotavirus Vaccines for use in Developing Countries, Geneva, January 9–10, 1997. Sponsored by: The Global Programme for Vaccines, World Health Organization, The Children's Vaccine Initiative and the Centers for Disease Control and Prevention.1. Vaccine 17:18, pages 2207-2222.
Crossref
Crossref
Jacek Z Mrukowicz, Juliette Thompson, George W Reed, Sharon J Tollefson, Masaaki Kobayashi, Kozuko Araki & Peter F Wright. (1999) Epidemiology of rotavirus in infants and protection against symptomatic illness afforded by primary infection and vaccination. Vaccine 17:7-8, pages 745-753.
Crossref
Crossref
T Vesikari. (1999) Rotavirus vaccine studies in Europe. Acta Paediatrica 88:s426, pages 9-13.
Crossref
Crossref
Robert M Jacobson. (1999) The current status of the rotavirus vaccine. Vaccine 17:13-14, pages 1690-1699.
Crossref
Crossref
S Ylitalo, M Uhari, S Rasi, J Pudas & J Leppäluoto. (2007) Rotaviral antibodies in the treatment of acute rotaviral gastroenteritis. Acta Paediatrica 87:3, pages 264-267.
Crossref
Crossref
Ulrich Desselberger. (1998) Prospects for vaccines against rotaviruses. Reviews in Medical Virology 8:1, pages 43-52.
Crossref
Crossref
Jaana Joensuu, Eeva Koskenniemi, Xiao-Li Pang & Timo Vesikari. (1997) Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. The Lancet 350:9086, pages 1205-1209.
Crossref
Crossref
J Aittoniemi, A Miettinen, P Laippala, E Isolauri, J Viikari, T Ruuska & E Soppi. (2008) Age‐dependent variation in the serum concentration of mannan‐binding protein. Acta Paediatrica 85:8, pages 906-909.
Crossref
Crossref
K MidthunA Z Kapikian. (1996) Rotavirus vaccines: an overview. Clinical Microbiology Reviews 9:3, pages 423-434.
Crossref
Crossref
T. Vesikari. 1996. Viral Gastroenteritis. Viral Gastroenteritis
177
186
.
Timo Vesikari & Albert Z. Kapikian. 1994. Modern Vaccinology. Modern Vaccinology
213
229
.
Timo Vesikari. (1993) Clinical trials of live oral rotavirus vaccines: the Finnish experience. Vaccine 11:2, pages 255-261.
Crossref
Crossref
K Y GreenA Z Kapikian. (1992) Identification of VP7 epitopes associated with protection against human rotavirus illness or shedding in volunteers. Journal of Virology 66:1, pages 548-553.
Crossref
Crossref
TARJA RUUSKA & TIMO VESIKARI. (2008) A Prospective Study of Acute Diarrhoea in Finnish Children from Birth to 2 1/2 Years of Age. Acta Paediatrica 80:5, pages 500-507.
Crossref
Crossref
TIMO VESIKARI, TARJA RUUSKA, ANDRÉE DELEM, FRANCIS E. ANDRÉ, GRAHAM M. BEARDS & THOMAS H. FLEWETT. (1991) Efficacy of Two Doses of RIT 4237 Bovine Rotavirus Vaccine for Prevention of Rotavirus Diarrhoea. Acta Paediatrica 80:2, pages 173-180.
Crossref
Crossref